Home » Topics » BioWorld Science

BioWorld Science
RSS

ATP spreads inflammation by activating neural pathway and enhancing IL-6 amplifier

June 9, 2022

French researchers patent gold complexes and their use as antioxidants

June 9, 2022

CURACLE and collaborators patent carbazole derivative angiogenesis inhibitors

June 9, 2022

Humanwell Healthcare discloses LPAR1 antagonists

June 9, 2022

WNT plays dual role in melanoma spread to lung

June 8, 2022

Coya raises financing to advance Treg-derived exosome therapeutics into clinic

June 8, 2022

Kiromic enters SRA with MD Anderson to support IND filings for gamma delta T-cell product candidates

June 8, 2022

Targeting NLRP3 inflammasome pathway prevents C. septicum-induced lethality

June 8, 2022

Find Therapeutics and SATT Conectus sign licensing agreement for new approach to treat MS

June 8, 2022

CiPA used to validate Axol's iPSC-derived ventricular cardiomyocytes for cardiac safety testing

June 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...